Project Grant R21AR083484
Award Date
8/1/24
Completion Date
6/30/26
Dollars Obligated
$198K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research into the role and regulation of the differentiation-specific keratin K9 in helping keratinocytes adapt to mechanical stress in the glabrous skin. The $208,160 award, granted to the Regents of the University of Michigan, will fund a study to define how K9 responds to...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research (CFDA 93.846) program, will enable Duke University to develop 3D in vitro skin models to investigate host-microbiome interactions in the skin. The $198,782 award will support the creation of genetically modified reconstructed human epidermis (RHE) cultures using CRISPR/Cas9 knockouts to identify how disruption of skin...
This federal Project Grant award of $176,148, awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support a 5-year research and career development plan for Dr. Maxime Kinet to study the role of PI16-expressing fibroblasts in mouse and human fibrosing skin disease. The research aims to elucidate the mechanisms by which this fibroblast subset responds to and...
This federal Project Grant award in the amount of $153,548.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award will support research to determine the cell autonomous mechanisms that permit and control cell proliferation during complex tissue regeneration in highly regenerative mammals such as spiny mice and rabbits. The objective is to identify how...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $401,433 from September 2023 to August 2025 to support research at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The research aims to investigate the role of protein O-GlcNAcylation in regulating keratinocyte function and its impact on skin...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $343,904.00 to The Regents of the University of California, San Francisco to investigate abnormal gene expression patterns in skin T cells of Asian and Hispanic patients with atopic dermatitis. The key objectives are to validate a set of elevated transcripts identified in these...
This $497,083 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support Harvard University's research into the mechanisms of scarless skin regeneration in fetal mice. The research aims to elucidate the genetic and molecular basis for the differential regenerative capacity between fetal and postnatal skin, with the goal of informing new...
This federal Project Grant award for $249,000.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant supports research by The Ohio State University to elucidate the mechanisms by which commensal microbes influence the development and function of skin monocytes in early life, and how these myeloid cells contribute to skin immune homeostasis. The project...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $652,729 to the Van Andel Research Institute (VAI) in Grand Rapids, Michigan. The award, effective August 19, 2024 through May 31, 2029, will support research to investigate the mechanisms by which the X-linked chromatin modifying enzyme KDM5C regulates female bone mass. The project aims to...
This federal Project Grant award of $550,909.00 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research into the intrinsic and extrinsic factors that regulate the competition for active TGFβ, which promotes the fitness of skin-resident memory CD8 T cells. The research aims to understand the basic biology of these resident memory T cells in the skin, including how...